title: Growth hormone replacement therapy is not associated with any increase in mortality. KIMS Study Group.
authors.forename: B A
authors.initials: BA
authors.lastname: Bengtsson
authors.forename: H P
authors.initials: HP
authors.lastname: Koppeschaar
authors.forename: R
authors.initials: R
authors.lastname: Abs
authors.forename: H
authors.initials: H
authors.lastname: Bennmarker
authors.forename: E
authors.initials: E
authors.lastname: Hernberg-Ståhl
authors.forename: B
authors.initials: B
authors.lastname: Westberg
authors.forename: P
authors.initials: P
authors.lastname: Wilton
authors.forename: J P
authors.initials: JP
authors.lastname: Monson
authors.forename: U
authors.initials: U
authors.lastname: Feldt-Rasmussen
authors.forename: C
authors.initials: C
authors.lastname: Wüster
mesh_terms: D000328:Adult; D003422:Critical Care; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000009:adverse effects* / Q000172:deficiency* / Q000627:therapeutic use; D006801:Humans; D009026:Mortality
chemical_list: D019382:Human Growth Hormone